Dan Pollyea, MD, MS
Professor, Medicine-Hematology

Clinical Director of Leukemia Services
Clinic (720) 848-6400
Print Profile
Email Profile
Featured Provider Photo

Gender: Male
Languages: English
Department, Section/Division: Medicine-Hematology

Practice Locations

UCHealth Blood Disorders and Cell Therapies Center - Anschutz Medical Campus
1665 Aurora Court
3rd floor, Anschutz Cancer Pavilion
Aurora, CO 80045
720-848-6400
More providers at this location

UCHealth Anschutz Inpatient Pavilion - Anschutz Medical Campus
12605 E. 16th Ave
Aurora, CO 80045
720-848-0000
More providers at this location

Hospital Affiliation
  • University of Colorado Hospital
Center Affiliations

Specialty Information

Specialties
  • Hematology, Board Certification (2010)
  • Internal Medicine, Board Certification (2006,2016)
  • Internal Medicine - Medical Oncology, Board Certification (2011)
Conditions & Treatments
  • Blood / Lymphatic System
  • Blood Disorders
  • Cancers
  • Leukemia (Adult Acute)
  • Leukemia (Adult Chronic)
  • Lymphoma
Clinical Interest for Patients
Optimal management of leukemias and their complications

Care Philosophy
I believe in finding the best, most cutting edge treatments to personalize care for my patients

Personal Interests
Dr. Pollyea received his MD degree from the University of Chicago Pritzker School of Medicine. He stayed at the University of Chicago Hospital for his residency in Internal Medicine and served as Chief Medical Resident at Cook County Hospital. He then completed his fellowship training in Hematology and Oncology at Stanford University, where he also completed a Masters degree in Epidemiology with an emphasis on biostatistics and clinical trial design. In 2011 he came to the University of Colorado where he is currently the Clinical Director of Leukemia Services. Dr. Pollyea has served as the Principal Investigator of multiple early-phase clinical trials, and has received funding for his work from the American Society of Hematology, the American Society of Clinical Oncology and the Leukemia and Lymphoma Society. He has over 80 peer-reviewed publications and has spoken at many national and international meetings.

Public Speaking
Yes
I am a frequent speaker to colleagues and patients on subjects related to AML, MDS and MPNs

Education & Training

Medical Schools:
  • MD, University of Chicago Division of the Biological Sciences The Pritzker School of Medicine (2003)

Graduate Schools:
  • MS, Stanford University (2011)

Undergraduate Schools:
  • BS, Indiana University–Bloomington (IN) (1999)

Residency Program:
  • John H Stroger Hospital of Cook County Program, Chief Resident, Internal Medicine (2007)
  • University of Chicago Program, Internal Medicine (2006)

Fellowships:
  • Stanford University Program, Hematology and Oncology (2010)

Recognition & Awards

  • Endowed Chair in Hematology Research, Robert H. Allen (2018)
    In academic medicine, endowed chairs are honors created by philanthropic funds to provide stable, long-term positions for highly accomplished scientists. The positions recognizes Dr. Pollyea's excellence in pushing forward the field of hematologic oncology and cancer clinical trials.
  • Chairman's Quality of Life Award, Leukemia and Lymphoma Society Rocky Mountain Chapter (2018)
  • Scholar in Clinical Research, Leukemia and Lymphoma Society (2018)
  • Outstanding Early Career Scholar, University of Colorado Department of Medicine (2015)
  • Research Training Workshop Participant, Translational Research Training in Hematology (TRTCH) (2013)
    Each year, 20 early-career scientists (10 from North America and 10 from Europe) are selected to participate in the rigorous training program led by faculty who are international leaders in hematology. Topics covered include biostatistics and biomarkers, genetics and molecular biology, ethics, and phase I clinical study design.
  • Research Training Participant, American Society of Hematology Clinical Research Training Institute (CRTI) (2008)
    The ASH Clinical Research Training Institute (CRTI) is a unique, year-long education and mentoring program for hematology fellows and junior faculty at academic medical centers. CRTI offers a broad education on clinical research methods, research collaborations, statistical analysis, and managing the demands of family and career. The goal of the program is to produce leaders armed with ideas for clinical hematology research and the tools and resources to make their ideas a reality. For more information, visit https://www.hematology.org/Awards/Career-Training/410.aspx

Professional Memberships

  • American Society of Clinical Oncology, Member
  • American Society of Hematology, Member
  • Leukemia and Lymphoma Society, Rocky Mountain Region, Board of Directors
  • National Comprehensive Cancer Network, Panelist (acute myeloid leukemia, myelodysplastic syndromes)

Research & Grants

Grants
  • Scholar in Clinical Research (2019)
    Leukemia and Lymphoma Society, $00
  • Special Fellow in Clinical Research (2010)
    Leukemia and Lymphoma Society, $$195,000
Research interests for Patients:
Dr. Pollyea’s research interests involve developmental therapeutics for myeloid malignancies (myelodysplastic syndromes and acute myeloid leukemia) through collaborative laboratory-based efforts and clinical trials involving novel therapies that he designs and leads. He is interested in developing drugs that target leukemia stem cells that will allow for definitive and curative therapies.

Information for Referring Providers

Clinical Interests for Referring Providers
I am involved in clinical and translational research around the characterization and understanding of leukemia stem cells, and value communication with patients and referring providers


Clinic Phone: (720) 848-6400

CV Pollyea CV2019 Public (Received from DP 5.12.19).docx